Medicated Skincare - US - July 2018
US $4,395.00 (Excl.Tax)Excl. Tax Buy Now
"The medicated skincare market grew by 0.4% in 2017 and will reach an estimated $1.1 billion in 2018; an increase of just $14 million. Through 2023, Mintel estimates that the market will add between 1% and 3% per annum. Better prevention, oral medications, and non-medicated products will continue to challenge the category.
Yet, there are opportunities. Multifunctional products, fast-acting cold sore and skin growth removers and ancillary products that help consumers avoid the triggers of skin ailments will allow forward looking brands to reinvent their portfolios for an evolving market."
- Jamie Rosenberg, Global Personal Care Analyst
This report examines the following issues:
This report will give you a complete 360-degree view of your market. Not only is it rooted in robust proprietary and high-quality third-party data, but our industry experts put that data into context and you’ll quickly understand:
What They Want. Why They Want It.
Who’s Winning. How To Stay Ahead.
Size, Segments, Shares And Forecasts: How It All Adds Up.
New Ideas. New Products. New Potential.
Where The White Space Is. How To Make It Yours.
What’s Shaping Demand – Today And Tomorrow.